Physta
Commercial- Indications
- Sexual health, Energy, Immune system support
Company intelligence / Profile preview
Biotropics Malaysia has developed a portfolio of proprietary standardized herbal extracts—such as Physta® Tongkat Ali and SLP+® Kacip Fatimah—that have undergone extensive clinical validation. Their products are commercialized globally in over 35 countries. Clinical studies have demonstrated efficacy for men’s vitality and testosterone enhancement as well as women’s cardiovascular and menopausal health. The company operates the largest herbal extraction facility in Malaysia with US FDA inspection status.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biotropics Malaysia.